Innate Pharma logo

Innate Pharma

IPHA | NASDAQ
Chart Builder DCF Calculator
$1.41
+$0.03 (+2.17%)
At close: Nov 16, 2026, 4:00 PM ET
$1.44
+$0.03 (+2.12%)
After-hours: Nov 16, 2026, 4:19 PM ET
+2.17%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
26.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #886/1021 (Top 87%)

Key Statistics

Market Data

Market Cap $150.85M
1D Range
1.31 1.41
52W Range
1.17 2.54

Valuation (TTM)

PE -2.37
PB -3.26
EV/EBITDA -2.85

Valuation (NTM)

Forward PE 40.01
Forward PEG 0.03
Price Target $7.00
Loading financial charts...

Profile

Innate Pharma S.A. is a biotechnology firm, founded in 1999 and headquartered in Marseille, France, that specializes in the discovery, development, and market introduction of therapeutic antibodies. T...

Sector Healthcare
Industry Biotechnology
Employees 163
IPO Date Oct 17, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.24
Beat +18.12%
REV
$6.5M
Beat +2.38%
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$7.00
Upside
+396.45%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.